Clinical Trial Update: Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating low-dose Vitamin K as an adjuvant to Warfarin to improve anticoagulation control; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coagulation Disorders

Drugs mentioned

• Vitamin K (Vitamin K)
• Warfarin (warfarin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Coagulation | Phase 3 | Status: COMPLETED